These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 14115964)
21. Oncogene involvement in tumor regression: H-ras activation in the rabbit keratoacanthoma model. Corominas M; Leon J; Kamino H; Cruz-Alvarez M; Novick SC; Pellicer A Oncogene; 1991 Apr; 6(4):645-51. PubMed ID: 1840681 [TBL] [Abstract][Full Text] [Related]
22. Immunological reaction in keratoacanthoma, a spontaneously resolving skin tumor. Brown FC; Tan EM Cancer Res; 1973 Sep; 33(9):2030-3. PubMed ID: 4579773 [No Abstract] [Full Text] [Related]
23. [Ferguson-Smith type of curable spontaneous epitheliomatosis]. Belaïch S; Escande JP; Crickx B; Préaux J; Texier M; Duperrat-Noury G; Lok C Ann Dermatol Venereol; 1985; 112(9):697-8. PubMed ID: 4091418 [No Abstract] [Full Text] [Related]
29. [TUMORS OF THE SKIN IN RATS INDUCED BY 9,10-DIMETHYL-1,2-BENZANTHRACENE]. TURUSOV VS Arkh Patol; 1964; 26():44-50. PubMed ID: 14182492 [No Abstract] [Full Text] [Related]
30. Histopathological diagnosis of epithelial crateriform tumors: Keratoacanthoma and other epithelial crateriform tumors. Ogita A; Ansai SI; Misago N; Anan T; Fukumoto T; Saeki H J Dermatol; 2016 Nov; 43(11):1321-1331. PubMed ID: 27076258 [TBL] [Abstract][Full Text] [Related]
31. [CONSIDERATIONS ON THE CURE OF PIGMENTED NEVI OF MALIGNANT MELANOMAS AND THE PRECANCEROUS MELANOSIS OF DUBHREUIHL]. MORONI P Arch Ital Dermatol Venereol Sessuol; 1963 Oct; 32():124-41. PubMed ID: 14104037 [No Abstract] [Full Text] [Related]
32. THE TREATMENT OF MALIGNANT DISEASE OF THE EXTREMITIES BY MEGAVOLTAGE IRRADIATION UNDER TOURNIQUET ANOXIA. VANDENBRENK HA; MADIGAN JP; KERR RC; CASS NM; RICHTER W J Coll Radiol Australas; 1963 Oct; 7():142-58. PubMed ID: 14074363 [No Abstract] [Full Text] [Related]
33. The paradoxical association of regression with a poor prognosis in melanoma contrasted with a good prognosis in keratoacanthoma. Prehn RT Cancer Res; 1996 Mar; 56(5):937-940. PubMed ID: 8640780 [TBL] [Abstract][Full Text] [Related]
34. BASAL CELL CARCINOMA OF THE SKIN. GAETHE G J La State Med Soc; 1964 Jun; 116():218-20. PubMed ID: 14154835 [No Abstract] [Full Text] [Related]
35. [CONTRIBUTION TO THE CLINICAL PICTURE AND RADIOTHERAPY OF BRILL-SYMMERS DISEASE]. HOPPE D Radiobiol Radiother (Berl); 1964; 5():129-36. PubMed ID: 14189185 [No Abstract] [Full Text] [Related]
36. [KERATOACANTHOMA AND STATISTICS OF SKIN CANCER]. VILANOVA X; RUEDA LA; ROMAGUERA C; CAPDEVILA JM Actas Dermosifiliogr; 1963; 54():273-7. PubMed ID: 14107590 [No Abstract] [Full Text] [Related]
37. Possible key role of granzyme B in keratoacanthoma regression. Batinac T; Zamolo G; Coklo M; Hadzisejdic I Med Hypotheses; 2006; 66(6):1129-32. PubMed ID: 16497444 [TBL] [Abstract][Full Text] [Related]
38. Clinical manifestations of cutaneous metastases: a review with special emphasis on cutaneous metastases mimicking keratoacanthoma. Riahi RR; Cohen PR Am J Clin Dermatol; 2012 Apr; 13(2):103-12. PubMed ID: 22229935 [TBL] [Abstract][Full Text] [Related]